Major Events:

Shijiazhuang Pharmaceutical Group (02005): Received drug production registration approval for Benidipine Hydrochloride Tablets

Hengrui Medicine (01276) received the Drug Clinical Trial Approval Notice for HRS-6093 tablets approved and issued by the National Medical Products Administration

Hengrui Medicine (01276): HRS-2162 injection received Drug Clinical Trial Approval Notice

BeiGene (06160) sold Imdelltra royalty rights to Royalty Pharma, receiving $885 million upfront payment

Verizon Therapeutics-B (09887): First patient successfully dosed in LBL-034 Phase II trial

Zhonghuan Semiconductor (01735) signed memorandum with EGN to develop photovoltaic power stations and build component production capacity in Oman

Fosun Pharma (01696) launched PixelPeel™ safe laser skin resurfacing treatment solution

China Shenhua Energy (01088): Jiujiang Phase II Unit 3 passed 168-hour trial operation

Sirnaomics-B (06669): Registration application for peripheral controllable mechanical detachment fibered coil with spring approved by China's National Medical Products Administration

Operating Performance:

Sinopharm Holdings (01099) released interim results, with net profit attributable to shareholders of RMB 3.466 billion, down 6.43% YoY

Jiantao Group (00148) announced interim results, with net profit attributable to shareholders of approximately HK$2.582 billion, up 71% YoY

China Overseas Grand Oceans Group (00081) released interim results, with profit attributable to shareholders of RMB 284 million, down 67.91% YoY

Sinochem Fertilizer (00297) announced interim results, with profit attributable to shareholders of RMB 1.104 billion, up 5.04% YoY

Yihai International (01579) released interim results, with profit attributable to shareholders of RMB 309 million, up 0.39% YoY

EdwardLean Group (09919) released interim results, with profit attributable to shareholders of RMB 32.028 million, up 19.25% YoY

GDH Guangnan (00124) released interim results, with profit attributable to shareholders of HK$282 million, turning from loss to profit YoY

KEEP (03650) achieved significant results from dual-track strategy in first half, with adjusted net profit of RMB 10.347 million, turning from loss to profit YoY

Maoyan Entertainment (01896) announced interim results, with adjusted net profit of approximately RMB 235 million, down 33.2% YoY

China Software International (00354) released interim results, with profit attributable to shareholders of RMB 316 million, up 10.4% YoY

BOE Varitronix (00710) announced interim results, with profit attributable to shareholders of approximately HK$180 million, up approximately 5% YoY

Green Tea Restaurant Group (06831) announced interim results, with adjusted net profit of approximately RMB 251 million, up 40.4% YoY

Henlius (02696) released interim results, with profit attributable to shareholders of RMB 390 million, up 0.99% YoY, with overseas product profits achieving over 200% breakthrough growth YoY

Anjoy Foods (02648) achieved revenue of approximately RMB 7.5646 billion in first half, up 1.2% YoY, proposing dividend of RMB 1.425 per share

Haidilao (06862) released interim results, with profit attributable to shareholders of RMB 1.759 billion, with delivery business revenue up nearly 60% YoY

Le Hua Entertainment (02306) released interim results, with profit attributable to shareholders of RMB 58.099 million, up 88.66% YoY

China Ruyi (00136) achieved dual growth in revenue and profit in first half, with adjusted net profit of approximately RMB 1.303 billion, up 139.62% YoY

Time Angel (06699) announced interim results, with profit attributable to owners of $14.643 million, up 362.65% YoY

Lens Technology (06613) announced interim results, with net profit attributable to shareholders of approximately RMB 1.143 billion, up approximately 32.68% YoY

Tiangong International (00826) released interim results, with profit attributable to shareholders of RMB 204 million, up 10.4% YoY